Latest news
Moleculin Biotech (MBRX) stake capped at 4.99% under Intracoastal warrants - Stock TitanStock Titan · Thu, 06 Aug 2026 21:27:27 GMTMoleculin Biotech, Inc. (MBRX) CFO buys 293,333 shares and 879,999 warrants - Stock TitanStock Titan · Wed, 05 Aug 2026 20:17:50 GMTMoleculin Biotech, Inc. (MBRX) CEO adds stock and 1.6M Series I warrants - Stock TitanStock Titan · Wed, 05 Aug 2026 20:17:13 GMTMoleculin Biotech (MBRX) CSO buys common stock and Series I Warrants - Stock TitanStock Titan · Wed, 05 Aug 2026 20:16:24 GMTPrice to sales forward of Moleculin Biotech, Inc. – LS:A41SET - TradingViewTradingView · Wed, 05 Aug 2026 13:01:15 GMTMoleculin reports promising preliminary phase II/III data for leukaemia drug Annamycin - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 13:56:06 GMTMoleculin Biotech Raises $9.3 Million Equity; Signs Placement, Purchase and Lock-Up Agreements - TradingViewTradingView · Mon, 03 Aug 2026 21:13:01 GMTMoleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML - The Indian PractitionerThe Indian Practitioner · Mon, 03 Aug 2026 12:46:33 GMT